Stockscreener 앱 받기
0.3443
4.36%
-0.0157
전일 마감가:
$0.36
열려 있는:
$0.376
하루 거래량:
226.41K
Relative Volume:
0.92
시가총액:
$21.97M
수익:
$263.68M
순이익/손실:
$-73.69M
주가수익비율:
-0.3108
EPS:
-1.1078
순현금흐름:
$63.85M
1주 성능:
-4.33%
1개월 성능:
+4.52%
6개월 성능:
-39.07%
1년 성능:
-89.63%
1일 변동 폭
$0.3434
$0.376
1주일 범위
$0.3434
$0.40
52주 변동 폭
$0.3013
$3.33
Bioceres Crop Solutions Corp Stock (BIOX) Company Profile
명칭
Bioceres Crop Solutions Corp
전화
54 34 1486 1100
주소
Ocampo 210 bis, Predio CCT, Rosario
Compare BIOX vs MMM, VMI, BBUC, GHC, PAM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIOX
Bioceres Crop Solutions Corp
|
0.3443 | 21.01M | 263.68M | -73.69M | 63.85M | -1.1078 |
MMM
3 M Co
|
182.90 | 91.92B | 25.02B | 2.80B | 2.06B | 5.1834 |
VMI
Valmont Industries Inc
|
493.64 | 9.61B | 4.16B | 375.05M | 345.54M | 18.02 |
BBUC
Brookfield Business Corp
|
29.38 | 6.48B | 11.64B | -650.00M | 71.34M | -8.344 |
GHC
Graham Holdings Co
|
1,185.71 | 5.08B | 4.98B | 306.64M | 285.69M | 67.59 |
PAM
Pampa Energia Sa Adr
|
82.36 | 4.61B | 2.02B | 399.23M | -286.30M | 7.3219 |
Bioceres Crop Solutions Corp Stock (BIOX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-09-10 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2024-07-19 | 재개 | Canaccord Genuity | Buy |
| 2024-07-02 | 재개 | ROTH MKM | Buy |
| 2023-04-06 | 개시 | Oppenheimer | Outperform |
| 2022-09-30 | 개시 | Canaccord Genuity | Buy |
| 2021-10-08 | 개시 | ROTH Capital | Buy |
| 2021-03-15 | 개시 | Lake Street | Buy |
모두보기
Bioceres Crop Solutions Corp 주식(BIOX)의 최신 뉴스
Bioceres Crop Solutions Corp (BIOX) Cash Flow - TradingKey
Bioceres Crop Solutions Corp (BIOX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bioceres Crop Solutions Corp (BIOX) Income Statement - TradingKey
Bioceres Crop Solutions Market Sentiment - Benzinga España
Bioceres Crop Solutions Corp - TradingKey
Bioceres Crop Solutions Corp (BIOX) Balance Sheet - TradingKey
BIOX|Bioceres Crop Solutions Corp|Price:0.343|Chg%:-0.005 - TradingKey
Bioceres Crop Solutions Corp (BIOX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BIOX|Bioceres Crop Solutions Corp|Price:0.333|Chg%:-0.010 - TradingKey
Bioceres Crop Solutions Corp (BIOX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bioceres Crop Solutions Corp. Revenue Breakdown – FWB:0G4 - TradingView
Bioceres Crop Solutions Corp (BIOX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bioceres Crop Solutions (BIOX) Q2 2025 earnings summary - Quartr
Bioceres Crop Solutions (BIOX) Q1 2026 earnings summary - Quartr
Bioceres Crop Solutions (BIOX) Q2 2026 earnings summary - Quartr
Bioceres Crop Solutions (BIOX) Q1 2025 earnings summary - Quartr
Bioceres Crop Solutions (BIOX) Registration Filing Summary - Quartr
Bioceres Crop Solutions (BIOX) Q4 2025 earnings summary - Quartr
Narain Duraiswami Net Worth (2026) - GuruFocus
BIOX Q2 2026 Earnings: EPS Misses Estimates SignificantlyReturn On Assets - dars.gov.et
Bioceres Crop Solutions (BIOX) Edges Higher Amid Low-Price DynamicsRounding Top - dars.gov.et
BIOX News | BIOCERES CROP SOLUTIONS CORP (NASDAQ:BIOX) - ChartMill
Form 13D/A Bioceres Crop Solutions Corp. For: 7 July By Investing.com - Investing.com Nigeria
Major Bioceres (BIOX) shareholder trims stake, now reporting 5.83% - Stock Titan
Bioceres Crop Solutions Corp. (BIOX) Q2 2026 Earnings: EPS Misses Estimates, Stock Surges 8.46% on Positive SentimentPost-Earnings Drift - dars.gov.et
Enterprise value to revenue forward of Bioceres Crop Solutions Corp. – NASDAQ:BIOX - TradingView
Price to book forward of Bioceres Crop Solutions Corp. – NASDAQ:BIOX - TradingView
Price to earnings forward of Bioceres Crop Solutions Corp. – NASDAQ:BIOX - TradingView
BIOX Q2 2026 Earnings: EPS Misses Estimates Significantly, Stock DeclinesEarnings Decline Risk - dars.gov.et
Enterprise value to EBITDA forward of Bioceres Crop Solutions Corp. – NASDAQ:BIOX - TradingView
Enterprise value to EBITDA forward of Bioceres Crop Solutions Corp. – BOATS:BIOX - TradingView
Price to sales forward of Bioceres Crop Solutions Corp. – DUS:0G4 - TradingView
Bioceres (BIOX) Tests Key Support at $0.31 After Marginal DeclineLow Volatility Picks - dars.gov.et
Bioceres Crop Solutions Corp (BIOX) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Bioceres Crop Solutions Corp. Actuals & Estimates (NASDAQ:BIOX) - TradingView
Bioceres Crop Solutions Corp. Actuals & Estimates (DUS:0G4) - TradingView
Bioceres Crop Solutions Corp (BIOX) Institutional Confidence - TradingKey
Bioceres Crop Solutions updates earnings provision and reports court ruling By Investing.com - Investing.com Nigeria
Bioceres Crop Solutions updates earnings provision and reports court ruling - Investing.com
Bioceres Crop Solutions (NASDAQ: BIOX) posts 3Q26 loss and faces adverse liability ruling - Stock Titan
Bioceres Crop Solutions (BIOX) Edges Higher: Testing Key Resistance LevelEMA Signal - dars.gov.et
BIOX: Bioceres Crop Solutions Reports Outstanding 62% Comparable Revenue Growth for FY2022. Top-line of high margin HB4 products reported for first time. Baseline adjusted EBITDA increases 24% to $61. - Yahoo Finance
Bioceres Crop Solutions Corp (BIOX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bioceres Crop Solutions Corp (BIOX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bioceres Crop Solutions Corp (BIOX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bioceres Crop Solutions Reports Fiscal Third Quarter 2026 Financial and Operational Results - Global Agriculture
BIOX Q1 2026 Earnings: EPS Misses Estimates Sharply, Stock Declines Over 7%Earnings Yield Spread - newsline.com
Bioceres Crop Solutions Reports Net Loss Amid Litigation Process - HarianBasis.co
Bio-Path: Q1 Earnings Snapshot - AOL.com
Bioceres Crop Solutions (BIOX) investor trims stake to 4.4M shares - Stock Titan
Bioceres Crop Solutions Corp Maintains Gross Profit at Thirty Six Million Dollars - sekbernews.id
Bioceres Crop Solutions Corp (BIOX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.14%
4.14%
자본화:
|
볼륨(24시간):